ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Columbia Still In Running As Comprehensive Center In ’78; Illinois Withdraws Application

June 24, 1977

Intensive Chemo Equivalent To Transplant For MCL

December 26, 2008

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

Senate Votes To Invalidate Task Force Guideline

December 4, 2009

“With resources now constrained, the ability of NCI to be responsive to its constituencies has been compromised.”

July 7, 1995

DCT Planning To Stop Use Monkeys In Preclinical Test

November 17, 1978